Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 202014(2):185–192.
Fang L, Karakiulakis G, Roth M. Antihypertensive drugs and risk of COVID-19? Authors’ reply. Lancet Respir Med. 2020;8(5):e32–e33.
NephJC. ACE2 and Hypertension. Nephrology Social Media Collective. News, March 14, 2020 Web site. 2020. http://www.nephjc.com/news/covidace2. Accessed 3 Apr 2020.
Varrassi G. Warning against the use of anti-inflammatory medicines to cure COVID-19: building castles in the air. Adv Ther. 2020;37(5):1705–7.
FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367(6485):1434.
PubMed
Google Scholar
Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transpl. 2020;39(5):405–7.
Liu Q, Zhou YH, Yang ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol. 2016;13(1):3–10.
CAS
Article
PubMed
Google Scholar
Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.
CAS
Article
PubMed
PubMed Central
Google Scholar
La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol. 2007;85(2):85–92.
Article
PubMed
Google Scholar
Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.
CAS
Article
PubMed
PubMed Central
Google Scholar
Shi X, Zhou W, Huang H, et al. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care. 2013;17(6):R301.
Article
PubMed
PubMed Central
Google Scholar
Zheng BJ, Chan KW, Lin YP, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA. 2008;105(23):8091–6.
CAS
Article
PubMed
PubMed Central
Google Scholar
Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 2020;37(1):61–82.
Article
PubMed
Google Scholar
Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev. 2020;19(5):102523.
Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29.
CAS
Article
PubMed
Google Scholar
Patrono C, Baigent C. Coxibs, traditional NSAIDs, and cardiovascular safety post-precision: what we thought we knew then and what we think we know now. Clin Pharmacol Ther. 2017;102(2):238–45.
CAS
Article
PubMed
Google Scholar
Solomon DH, Avorn J, Sturmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006;54(5):1378–89.
CAS
Article
PubMed
Google Scholar
Caughey GE, Cleland LG, Penglis PS, Gamble JR, James MJ. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol. 2001;167(5):2831–8.
CAS
Article
PubMed
Google Scholar
Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002;296(5567):539–41.
CAS
Article
PubMed
Google Scholar
Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen safety at the golden anniversary: are all NSAIDs the same? A narrative review. Adv Ther. 202037(1):61–82.
Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G. Influence of microbiota on NSAID enteropathy: a systematic review of current knowledge and the role of probiotics. Adv Ther. 2020;37(5):1933–45.
Article
PubMed
PubMed Central
Google Scholar
Sander WJ, O’Neill HG, Pohl CH. Prostaglandin E2 as a modulator of viral infections. Front Physiol. 2017;8:89.
Article
PubMed
PubMed Central
Google Scholar
Wen YC, Hsiao FY, Chan KA, Lin ZF, Shen LJ, Fang CC. Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: a nationwide case-crossover study. J Infect Dis. 2017;215(4):503–9.
Article
PubMed
Google Scholar
Voiriot G, Chalumeau M, Messika J, et al. Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia. Rev Mal Respir. 2018;35(4):430–40.
CAS
Article
PubMed
Google Scholar
Little P. Non-steroidal anti-inflammatory drugs and covid-19. Brit Med J. 2020;368:m1185.
Gov.UK. Commission on human medicines advice on ibuprofen and coronavirus (COVID-19). gov.UK. 2020. https://www.gov.uk/government/news/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19. Accessed 18 Apr 2020.
Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364–72.
CAS
Article
PubMed
Google Scholar